Highlights
- Aehr Test Systems secures its first AI processor customer, signaling strong market opportunities.
- Company maintains full-year guidance of at least $70 million in revenue for fiscal 2025.
- Despite challenges, Aehr’s backlog stands at $26.6 million, highlighting future growth potential.
Aehr Test Systems (NASDAQ:AEHR), a leading provider of test and burn-in equipment for the semiconductor industry, has reported its financial results for Q2 fiscal 2025, showing a decline in revenue but also highlighting significant strategic milestones. The company generated net revenue of $13.5 million for the quarter, which represents a 37% year-over-year decrease from $21.4 million in Q2 FY2024. This drop in revenue is partly attributed to timing delays in customer orders and lower-than-expected demand for some of its testing products.
In addition to the revenue decline, Aehr Test posted a GAAP net loss of $1.0 million for Q2 FY2025, or $0.03 per share, compared to a net income of $6.1 million, or $0.20 per share, in the same period last year. This shift to a loss reflects both the reduced revenue and increased operational costs associated with expanding the company’s product offerings and infrastructure.
However, despite the financial challenges, Aehr Test achieved several key milestones in its efforts to capitalize on emerging market opportunities. Notably, the company secured its first AI processor customer for wafer-level burn-in, a significant step forward in the rapidly growing artificial intelligence market. Additionally, Aehr received its first volume production orders for package part burn-in from an AI processor customer. This reflects the growing demand for the company’s testing equipment as AI processors are increasingly deployed in high-performance applications.
Aehr also made progress in the gallium nitride (GaN) space, securing its first GaN customer for high-volume production. GaN technology is critical for power electronics used in applications ranging from electric vehicles to 5G networks, and the demand for GaN-based solutions is expected to rise significantly in the coming years. The company's ability to secure customers in this field further strengthens its market position.
Looking ahead, Aehr Test remains optimistic about its prospects for fiscal 2025. The company is maintaining its full-year guidance, forecasting revenue of at least $70 million and a non-GAAP net profit before taxes of at least 10%. This guidance reflects the company’s confidence in its future orders and its ability to generate strong profit margins from its expanding customer base.
As of November 29, 2024, Aehr Test’s total cash and equivalents stood at $35.2 million, a decrease from $40.8 million in the prior quarter. The company’s backlog, however, remains robust at $26.6 million, suggesting that the company is positioned for a recovery in the second half of the fiscal year. Despite cash flow challenges, Aehr Test is confident in its ability to execute on upcoming orders.